Фиксированная комбинация b-блокатора и диуретика у пациентов с артериальной гипертонией высокого риска

1. Papademetriou V, Prisant LM, Weber M et al. Low-dose combination therapy in the management of hypertension. Primary Cardiol 1995; 21: 29-31.

2. Диагностика и лечение артериальной гипертензии. Российские рекомендации (4-й пересмотр). Системные гипертензии. 2010; 3: 3-25.

3. James IM. Which antihypertensive? Br J Clin Pract 1990; 44: 102-5.

4. Enlund H, Turakka H, Tuomilehto J. Combination therapy in hypertension: a population-based study in eastern Finland. Eur J Clin Pharmacol 1981; 21: 1-8.

5. Brunner HR, Menhard J, Waeber B et al. Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8: 3-11.

6. Epstein M, Bakris G. Newer approaches to antihypertensive therapy: use of fixed-dose combination therapy. Arch Intern Med 1996; 156: 1969-78.

7. Alderman MH. Which antihypertensive drugs first - and why! JAMA 1992; 267: 2786-7.

8. Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.

9. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-12.

10. Bakris GL, Frohlich ED. The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol 1989; 14: 1595-608.

11. Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313-21.

12. Чазова И.Е., Ратова Л.Г. Фиксированная комбинация b-блокатора и диуретика в лечении больных артериальной гипертонией. Системные гипертензии. 2010; 4: 25-8.

13. Dequattro V, Weir MR. Bisoprolol fumarate. Hydrochlorothiazide 6.25 mg: a new low-dose option for first-line antihypertensive therapy. Adv Ther 1993; 10: 197-206.

14. Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension: treatment with Bisoprolol and Hydrochlorothiazide. Arch Intern Med 1994; 154: 1461-8.

15. Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose Bisoprolol fumarate and low-dose Hydrochlo-rothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35: 182-8.

16. Neutel JM, Rolf CN, Valentine SN et al. Low-dose combination therapy as first line treatment of mild to moderate hypertension: the efficacy and safety of Bisoprolol/6.25 HCTZ versus Amlodipine, Enalapril, and placebo. Car-diovasc Rev Rep 1996; 17: 33-45.

17. Prisant LM, Weir MR, Papademetriou V et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130: 359-66.

18. Benetos A, Consoli S, Safavian A et al. Efficacy, safety, and effects on quality of life of Bisoprolol. Hydrochlorothiazide versus Amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140: e14.